Prevalence of Adverse Events in Mexico Using the Institute for Healthcare Improvement—Global Trigger Tool Method: A Retrospective Study

IF 2.1 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES
Luis Meave Gutierrez-Mendoza, Elizabeth Manias, Patricia Nicholson
{"title":"Prevalence of Adverse Events in Mexico Using the Institute for Healthcare Improvement—Global Trigger Tool Method: A Retrospective Study","authors":"Luis Meave Gutierrez-Mendoza,&nbsp;Elizabeth Manias,&nbsp;Patricia Nicholson","doi":"10.1111/jep.70405","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Rationale</h3>\n \n <p>Globally, adverse events (AEs) are a major contributor to mortality, often arising from healthcare management rather than patients' underlying conditions.</p>\n </section>\n \n <section>\n \n <h3> Aims and Objectives</h3>\n \n <p>This study aimed to estimate the prevalence of AEs in three different hospitals in central-north Mexico using the Institute for Healthcare Improvement Global Trigger Tool (IHI-GTT) method.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>A retrospective review of hospital discharges (July 2022 to June 2023) was conducted in three hospitals using the IHI-GTT method. Records of patients aged ≥ 18 years with hospital stays longer than 24 h were reviewed, with obstetric and paediatrics cases excluded. One experienced physician performed the two-stages review process, with inter-rater reliability assessed on 1% of records. Logistic regression analysis was used to identify factors associated with AEs.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 3354 discharges, 36.6% (<i>n</i> = 1227) experienced at least one adverse event (AE), corresponding to 72.79 AEs per 1000 patient-days or 53.04 AEs per 100 admissions. Of these, 72.8% (<i>n</i> = 893) were preventable. The most frequent AEs were medication errors (23.6%), intravenous line errors (23.5%), hospital acquired infections (16.4%), and surgical (9.9%). The AEs contributed to the death of the patient in 14.6% (<i>n</i> = 179) of cases. Risk factors for AEs included hospital transfers (OR: 1.53; 95% CI: 1.25–1.87, <i>p</i> &lt; 0.001), age ≥ 60 years (OR: 1.49; 95% CI: 1.22–1.83, <i>p</i> &lt; 0.001), comorbidities (OR: 1.15; 95% CI: 1.08–1.23, <i>p</i> &lt; 0.001), and longer hospital stay (OR: 1.13; 95% CI: 1.11–1.14, <i>p</i> &lt; 0.001). Elective admissions showed a protective effect (OR: 0.77; 95% CI: 0.62–0.97, <i>p</i> = 0.027).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The prevalence of AEs in Mexico, a middle-income country, is higher than previously reported. These finding underscore a pressing public health challenge requiring targeted interventions.</p>\n </section>\n </div>","PeriodicalId":15997,"journal":{"name":"Journal of evaluation in clinical practice","volume":"32 2","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002140/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of evaluation in clinical practice","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jep.70405","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale

Globally, adverse events (AEs) are a major contributor to mortality, often arising from healthcare management rather than patients' underlying conditions.

Aims and Objectives

This study aimed to estimate the prevalence of AEs in three different hospitals in central-north Mexico using the Institute for Healthcare Improvement Global Trigger Tool (IHI-GTT) method.

Method

A retrospective review of hospital discharges (July 2022 to June 2023) was conducted in three hospitals using the IHI-GTT method. Records of patients aged ≥ 18 years with hospital stays longer than 24 h were reviewed, with obstetric and paediatrics cases excluded. One experienced physician performed the two-stages review process, with inter-rater reliability assessed on 1% of records. Logistic regression analysis was used to identify factors associated with AEs.

Results

Among 3354 discharges, 36.6% (n = 1227) experienced at least one adverse event (AE), corresponding to 72.79 AEs per 1000 patient-days or 53.04 AEs per 100 admissions. Of these, 72.8% (n = 893) were preventable. The most frequent AEs were medication errors (23.6%), intravenous line errors (23.5%), hospital acquired infections (16.4%), and surgical (9.9%). The AEs contributed to the death of the patient in 14.6% (n = 179) of cases. Risk factors for AEs included hospital transfers (OR: 1.53; 95% CI: 1.25–1.87, p < 0.001), age ≥ 60 years (OR: 1.49; 95% CI: 1.22–1.83, p < 0.001), comorbidities (OR: 1.15; 95% CI: 1.08–1.23, p < 0.001), and longer hospital stay (OR: 1.13; 95% CI: 1.11–1.14, p < 0.001). Elective admissions showed a protective effect (OR: 0.77; 95% CI: 0.62–0.97, p = 0.027).

Conclusion

The prevalence of AEs in Mexico, a middle-income country, is higher than previously reported. These finding underscore a pressing public health challenge requiring targeted interventions.

Abstract Image

墨西哥不良事件流行率使用卫生保健改善研究所-全球触发工具方法:回顾性研究。
理由:在全球范围内,不良事件(ae)是死亡率的主要原因,通常由医疗保健管理引起,而不是患者的潜在条件。目的和目的:本研究旨在使用卫生保健改善研究所全球触发工具(IHI-GTT)方法估计墨西哥中北部三家不同医院的ae患病率。方法:采用IHI-GTT方法对三家医院(2022年7月至2023年6月)的出院情况进行回顾性分析。回顾了年龄≥18岁且住院时间超过24小时的患者的记录,排除了产科和儿科病例。一位经验丰富的医生进行了两阶段的评估过程,评估了1%的记录的内部可靠性。采用Logistic回归分析确定与ae相关的因素。结果:在3354例出院患者中,36.6% (n = 1227)的患者至少发生一次不良事件(AE),相当于每1000患者日发生72.79例AE或每100例住院患者发生53.04例AE。其中,72.8% (n = 893)是可以预防的。最常见的ae是用药错误(23.6%)、静脉输注错误(23.5%)、医院获得性感染(16.4%)和手术(9.9%)。14.6% (n = 179)的ae导致患者死亡。不良事件的危险因素包括医院转院(OR: 1.53; 95% CI: 1.25-1.87, p)。结论:中等收入国家墨西哥的不良事件发生率高于先前报道。这些发现强调了一项迫切的公共卫生挑战,需要有针对性的干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.80
自引率
4.20%
发文量
143
审稿时长
3-8 weeks
期刊介绍: The Journal of Evaluation in Clinical Practice aims to promote the evaluation and development of clinical practice across medicine, nursing and the allied health professions. All aspects of health services research and public health policy analysis and debate are of interest to the Journal whether studied from a population-based or individual patient-centred perspective. Of particular interest to the Journal are submissions on all aspects of clinical effectiveness and efficiency including evidence-based medicine, clinical practice guidelines, clinical decision making, clinical services organisation, implementation and delivery, health economic evaluation, health process and outcome measurement and new or improved methods (conceptual and statistical) for systematic inquiry into clinical practice. Papers may take a classical quantitative or qualitative approach to investigation (or may utilise both techniques) or may take the form of learned essays, structured/systematic reviews and critiques.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书